Neuronetics to Report Second Quarter 2022 Financial and Operating Results and Host Conference Call
MALVERN, Pa., July 19, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on...
Neuroscience
Celsion Appoints Dr. Corinne Le Goff as President and Chief Executive Officer
Michael H. Tardugno appointed Executive Chairman of the Board LAWRENCEVILLE, N.J., July 19, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN),...
NeuroStar® Advanced Therapy for Mental Health Receives FDA Clearance for Treatment of Anxious Depression
Indication demonstrates NeuroStar TMS safety and efficacy in improving anxiety symptoms in depressed patientsMALVERN, Pa., July 19, 2022 (GLOBE NEWSWIRE)...
Novartis delivers continued strong momentum of key growth brands, progress on strategic initiatives and confirms FY’22 Group guidance
Ad hoc announcement pursuant to Art. 53 LR Q2 sales grew +5% cc1 (-1% USD) Innovative Medicines (IM) sales grew...
Reflect Partners with Trust Relations to Promote its Anxiety Tech ‘Orb’ to Help You Reach Your Calmest State through Meditation
Reflect's consumer tech devices create and track mindful moments using biofeedback so you can train your body to self-soothe in...
Rune Labs Partners with Coastal Research Institute to Identify Biomarkers of Multiple Sclerosis Lesions using AI Platform to Analyze Patient Neurophysiological Data
Quantitative biomarkers of demyelination can improve clinical trial design and accelerate development of disease-modifying therapeutics SAN FRANCISCO, July 14, 2022...
Medtronic receives FDA clearance for next-generation UNiD™ Spine Analyzer with degenerative spine surgery predictive model
Powered by a database of over 10,000 surgical cases, Medtronic continues to evolve the UNiD™ platform to help surgeons plan...
SPR Therapeutics to Present Clinical Trial and Real-World Findings at ASPN 2022
CLEVELAND, July 14, 2022 (GLOBE NEWSWIRE) -- SPR Therapeutics announced today that two presentations highlighting SPRINT® PNS in treating chronic...
Pasithea Therapeutics Awarded a Drug Development Research Grant
-- AUD $1 million (U.S $694,000) grant transferred as part of Alpha-5 Integrin, LLC transaction ---- Provides approximately U.S. $694,000...
Measuring Subtypes of Concussion with EYE-SYNC
Over the past two years, many of the world’s foremost researchers and leading clinical experts from across the United States have...